Diagnostics & Research
The Diagnostics & Research industry has a total of 45 stocks, with a combined market cap of $737.26 billion, total revenue of $168.76 billion and a weighted average PE ratio of 42.14.
Market Cap
737.26B
Revenue
168.76B
Profits
17.49B
PE Ratio
42.14
Profit Margin
10.37%
Dividend Yield
0.22%
45 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 190.65B | 1.44% | 4,569,993 | 45.20B |
| 2 | DHR | Danaher Corporation | 138.86B | 1.75% | 6,090,465 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 43.50B | -0.62% | 1,314,689 | 4.45B |
| 4 | A | Agilent Technologies, Inc. | 38.41B | 0.37% | 3,133,339 | 7.23B |
| 5 | NTRA | Natera, Inc. | 37.51B | 0.45% | 3,411,831 | 2.50B |
| 6 | WAT | Waters Corporation | 36.76B | -0.66% | 2,032,520 | 3.77B |
| 7 | IQV | IQVIA Holdings Inc. | 31.90B | 2.53% | 1,775,154 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 26.71B | -0.62% | 2,196,196 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 25.54B | 1.64% | 381,159 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 23.23B | 1.76% | 1,349,740 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 22.26B | 1.93% | 1,034,002 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 19.79B | 4.39% | 18,771,521 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.05B | 1.37% | 399,908 | 2.68B |
| 14 | ICLR | ICON Public Limited Company | 13.01B | 5.53% | 1,443,048 | 8.27B |
| 15 | RVTY | Revvity, Inc. | 12.61B | -0.45% | 3,674,633 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 10.39B | 1.43% | 1,445,803 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 8.15B | 1.21% | 3,629,044 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 6.22B | 3.30% | 4,274,957 | 409.48M |
| 19 | BLLN | BillionToOne, Inc. | 5.44B | 5.28% | 962,344 | 354.54M |
| 20 | SHC | Sotera Health Company | 4.96B | 1.64% | 3,945,429 | 1.19B |
| 21 | VCYT | Veracyte, Inc. | 4.83B | 3.31% | 3,333,219 | 541.74M |
| 22 | RDNT | RadNet, Inc. | 4.78B | 1.22% | 2,978,742 | 2.14B |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 3.35B | 3.51% | 6,474,446 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 2.83B | -0.98% | 1,725,920 | 156.12M |
| 25 | WGS | GeneDx Holdings Corp. | 2.07B | 1.67% | 1,379,115 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.85B | 3.20% | 7,125,311 | 745.97M |
| 27 | CDNA | CareDx, Inc. | 1.49B | 3.48% | 1,646,862 | 412.82M |
| 28 | PSNL | Personalis, Inc. | 1.36B | 3.42% | 8,354,777 | 64.52M |
| 29 | OPK | OPKO Health, Inc. | 1.16B | 1.32% | 8,415,322 | 581.12M |
| 30 | CSTL | Castle Biosciences, Inc. | 737.02M | 6.07% | 1,043,840 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 566.88M | 2.67% | 505,897 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 555.36M | 8.29% | 5,205,834 | 829.00M |
| 33 | BDSX | Biodesix, Inc. | 235.93M | 16.47% | 154,541 | 96.10M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 174.37M | -3.40% | 82,257 | 1.95M |
| 35 | XGN | Exagen Inc. | 110.65M | -1.29% | 404,581 | 68.38M |
| 36 | BNR | Burning Rock Biotech Limited | 87.22M | 4.03% | 10,008 | 74.58M |
| 37 | PRPO | Precipio, Inc. | 41.66M | 1.78% | 54,316 | 25.83M |
| 38 | QUCY | Quantum Cyber N.V. | 23.90M | 12.41% | 65,779,351 | 537.08K |
| 39 | MDXH | MDxHealth SA | 21.92M | -6.12% | 1,315,090 | 110.97M |
| 40 | XWEL | XWELL, Inc. | 8.95M | 1.92% | 82,838 | 28.83M |
| 41 | MBAI | Check-Cap Ltd. | 7.94M | -1.80% | 42,158 | - |
| 42 | ADVB | Advanced Biomed Inc. | 7.42M | -10.02% | 3,896 | - |
| 43 | NDRA | ENDRA Life Sciences Inc. | 6.34M | 16.05% | 158,731 | - |
| 44 | ISPC | iSpecimen Inc. | 3.84M | 3.89% | 51,792 | 1.03M |
| 45 | BIAF | bioAffinity Technologies, Inc. | 3.76M | -1.23% | 146,271 | 5.66M |